Work

S941 Comparative Efficacy and Safety of Adalimumab vs Vedolizumab in Managing Moderate-to-Severe Crohn's Disease: A Systematic Review and Meta-Analysis

Year: 2023

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000953404.12751.ab

Authors: Nooraldin Merza, Alsadiq Al-Hillan, Sarmed Mansur, Fatima A. Merza, Mohamad Nawras, Dushyant Singh Dahiya, Safa Boujemaa, Tarek Naguib, Abdallah A. Kobeissy, Mona Hassan, Asm Islam, Yaseen Alastal

Institutions: University of Toledo, University of Michigan, University of Kansas, University of Kansas Medical Center, Institut Pasteur de Tunis, Texas Tech University

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387733646

Cites:

Cited by:

Related to: 10